Cargando…
Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing
To assess public attitudes and interest in pharmacogenetic (PGx) testing, we conducted a random-digit-dial telephone survey of U.S. adults, achieving a response rate of 42% (n=1139). Most respondents expressed interest in PGx testing to predict mild or serious side effects (73% ±3.29% and 85% ±2.91%...
Autores principales: | Haga, Susanne B., O’Daniel, Julianne M., Tindall, Genevieve M., Lipkus, Isaac R., Agans, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139751/ https://www.ncbi.nlm.nih.gov/pubmed/21321582 http://dx.doi.org/10.1038/tpj.2011.1 |
Ejemplares similares
-
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
por: Haga, Susanne B.
Publicado: (2023) -
Revisiting Secondary Information Related to Pharmacogenetic Testing
por: Haga, Susanne B.
Publicado: (2021) -
Delivering pharmacogenetic testing in a primary care setting
por: Mills, Rachel, et al.
Publicado: (2013) -
Pharmacogenetic information for patients on drug labels
por: Haga, Susanne B, et al.
Publicado: (2014) -
Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing
por: Haga, Susanne B, et al.
Publicado: (2021)